Rob Schilling is a seasoned Clinical Program Director with extensive experience in oncology and diagnostics within the pharmaceutical industry. Currently at Genentech since July 2013, Rob has been responsible for developing operational strategies for Early Development programs, managing study timelines and budgets, and providing leadership to clinical operations teams. Previous roles include Director of Clinical Operations at Roche Molecular Systems, where Rob led Companion Diagnostic trials and established significant department capabilities. Other positions held encompass leadership and management at Elan Pharmaceuticals, Actelion, CoTherix, VaxGen, and PPD, demonstrating a strong background in clinical operations, regulatory compliance, and team management. Rob holds a Master of Public Health in Epidemiology from Loma Linda University and a Bachelor of Arts in Biochemistry from Azusa Pacific University.
This person is not in any teams
This person is not in any offices